LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/“First-Ever” De Novo Approval for LOADPRO Spinal Rod Strain Sensor
Legal & Regulatory and Reimbursement

“First-Ever” De Novo Approval for LOADPRO Spinal Rod Strain Sensor

April 8, 2019 2 min read Premium comments

Advertisement

“First-Ever” De Novo Approval for LOADPRO Spinal Rod Strain Sensor
LOADPRO Intraoperative Rod Strain Sensor / Source: Intellirod Spine
Secondary#denovoapproval#loadpro#spinalrodstrainsensor

Akron, Ohio-based Intellirod Spine says it has received a “first-ever” FDA De Novo Approval for its disposable spinal rod strain sensor, the LOADPRO.

According to the FDA, the De Novo process provides a pathway to Class I or Class II classification for medical devices for which general controls or general and special controls “provide a reasonable assurance of safety and effectiveness,” but for which there is no legally marketed predicate device.

An April 1, 2019 company announcement states “…the device clamps onto a standard 5.5mm rod for use in monitoring rod strain during a kyphotic correction surgery. This initial approval is for use of LOADPRO with the FORTEX pedicle screw system from Xtant Medical.”

Intellirod’s CEO, Ric Navarro, said this is “the first device in this new FDA product category for spine to give the surgeon unprecedented new information about how much strain is on their rods as they correct a deformity. Now the surgeon can quantify their tactile feel and be knowledgeable of the strain level as it relates to the yield limits of the rod material.”

Getting through the FDA without a predicate is an extra challenge. Justin Eggleton, vice president of Spine Regulatory Affairs for MCRA LLC, the clinical research organization and advisory firm that assisted Intellirod, said, “Intellirod Spine’s collaboration with FDA demonstrates the value of including the Agency early in the process to ensure all evaluations are focused on yielding data that speaks to the benefit-risk profile.”

Rolando Puno, M.D., company co-founder and spine surgeon at the Leatherman Spine Center in Louisville, Kentucky, said, “Post-market studies will add greater understanding of strains induced on the rods, the effect of different surgeon techniques on rod strain, and how reproducible procedures are relative to rod strain. Ultimately, we want to understand how our loading of the implants during surgery can affect the outcomes. Implant-related complications in long construct kyphotic deformities can be as high as 20%. LOADPRO gives us the tool to do these investigations and to learn the implications of our techniques.”

The company stated it plans to do site releases of the product in Cleveland, Ohio, and Louisville, Kentucky and expand its commercial launch sites. The company also plans to seek future FDA approvals with additional pedicle screw systems.

The company, formerly known as OrthoData, Inc., is developing multiple wearable, disposable and implantable wireless sensors.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy